Larotrectinib (LOXO-101)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 03:20, 27 November 2018 by Jwarner (talk | contribs) (Jwarner moved page Larotrectinib (LOXO-101) to Larotrectinib (Vitrakvi): FDA approval)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://hemonc.org/w/index.php?title=Larotrectinib_(LOXO-101)&oldid=32864"